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Background: In their book Spare Parts, published in 1992, Fox and Swazey criticized various aspects of organ
transplantation, including the routinization of the procedure, ignorance regarding its inherent uncertainties, and the
ethos of transplant professionals. Using this work as a frame of reference, we analyzed articles on organ
transplantation published in internal medicine and transplantation journals between 1995 and 2008 to see whether
Fox and Swazey’s critiques of organ transplantation were still relevant.
Methods: Using the PubMed database, we retrieved 1,120 articles from the top ten internal medicine journals and
4,644 articles from the two main transplantation journals (Transplantation and American Journal of Transplantation).
Out of the internal medicine journal articles, we analyzed those in which organ transplantation was the main topic
(349 articles). A total of 349 articles were randomly selected from the transplantation journals for content analysis.
Results: In our sample, organ transplantation was described in positive terms and was presented as a routine
treatment. Few articles addressed ethical issues, patients’ experiences and uncertainties related to organ
transplantation. The internal medicine journals reported on more ethical issues than the transplantation journals.
The most important ethical issues discussed were related to the justice principle: organ allocation, differential access
to transplantation, and the organ shortage.
Conclusion: Our study provides insight into representations of organ transplantation in the transplant and general
medical communities, as reflected in medical journals. The various portrayals of organ transplantation in our sample
of articles suggest that Fox and Swazey’s critiques of the procedure are still relevant.
Keywords: Organ transplantation, Ethical issues, Medical journals, Transplantation journals,
Thematic content analysisBackground
In the 1950s, the possibility of replacing a damaged organ
with a healthy one became a reality with the first success-
ful renal transplantations. A number of technologically-
driven advances in biomedicine followed in the 1960s,
including dialysis, life-support treatment, definition of
death and, particularly, the first heart transplantation
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reproduction in any medium, provided the orIn the early days, organ transplantation was considered
a “desperate [remedy] for desperate patients” [2], p.1483.
With the development of immunosuppressive therapies,
however, the field rapidly expanded. Nowadays, organ
transplantation is widely accepted, despite a number of
unresolved ethical issues. Transplantation challenges
several accepted boundaries between self and non-self,
body and machine, life and death, giving and receiving.
The entanglement of social, cultural, medical and eco-
nomic factors highlights the inherent complexity of this
procedure [3]. Two authors who tackled this complexity
were Renée C. Fox and Judith Swazey. They were privileged
“journeyers into the field, participant observers, and chroni-
clers . . .” [4], p.197. However, they eventually decided to
leave the field for reasons stated in the last chapter of their
seminal work Spare Parts (1992): the routinization of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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triumphalist attitude of professionals who believe “death is
our enemy”; nonchalant attitudes regarding the complex-
ities of gift exchange; the massive financial investment in
transplantation as opposed to other types of health care;
and a general reluctance to consider the inherent uncer-
tainties in this area of medicine [4]. The concept of uncer-
tainty refers to difficulties in diagnosing, treating and
accurately predicting the evolution and prognosis of indi-
vidual patients. According to Renée Fox, this could stem
from a physician’s personal ignorance, limits in actual
medical knowledge, or a combination both, and is a source
of anxiety for the patient, the physician and society. Med-
ical and scientific advances do not rule out uncertainty,
but modify its content and create new areas of uncertainty
that were not previously known [5,6].
In a previous study on portrayals of organ transplant-
ation in Quebec newspapers between 1995 and 2008, we
found a similar lack of questioning with regard to the
practice of transplantation. Although there was not a lot
of hype around transplantation per se, journalists tended
to overemphasize its successful, positive aspects. The
focus was generally on patients’ and close relatives’ per-
spectives: the uncertainty of being transplanted, the des-
perate waiting for an organ, the medical procedure, and
successful outcomes, with transplanted patients going
on to live full lives (e.g., through pregnancy and athletic
exploits). These articles did not look at complications, ad-
verse effects, organ rejection and graft failure. The only
two ethical issues mentioned were the selection of patients
for the waiting list and the allocation of organs [7]. The
newspaper coverage tended to exaggerate the “miraculous”
aspect of transplantation and emphasize successful out-
comes, leading patients to seek transplantation at any cost.
These findings echoed Fox and Swazey’s observations in
the early 1990s.
We wondered whether portrayals of organ transplant-
ation in medical journals would be similar to those in the
popular press, and whether Fox and Swazey’s analysis con-
tinued to be relevant and appropriate. We therefore fo-
cused the present study on the vocabulary used to
describe transplantation, the ethical issues raised, patients’
experiences and the theme of uncertainty in internal
medicine and transplantation journal articles published
between 1995 and 2008.
Methods
We selected the internal medicine and transplantation
journals according to their impact factor, since this gen-
erally reflects the quality, prestige and readership of the
journal. The top ten internal medicine journals (New
England Journal of Medicine, JAMA, The Lancet, Annals
of Internal Medicine, British Medical Journal, Annual
Review of Medicine, Archives of Internal Medicine,CMAJ, Annals of Medicine and PLoS Medicine) and the
two most important transplantation journals (Trans-
plantation and the American Journal of Transplant-
ation) were chosen. We limited our choice to these two
transplantation journals, because they publish articles on
different solid organ transplantations and are highly in-
fluential in the field. They are also the journals of leading
transplantation societies: The Transplantation Society
(Transplantation), and the American Society of Trans-
plantation and the American Society of Transplant Sur-
geons (American Journal of Transplantation).
We searched the PubMed database using the following
keywords to retrieve articles published between January 1,
1995, and December 31, 2008: transplantation or graft
AND organ or liver or kidney or heart or lung or pancreas.
We chose to look at this time period for two reasons: (i) it
marked the arrival of the latest immunosuppressive drugs
(Tacrolimus and Mycophenolate) which helped decrease
the incidence of acute rejection [8,9], and (ii) it coincided
with the period of our previous study on portrayals of
organ transplantation in Quebec newspapers [7]. We re-
trieved 1,120 articles from the internal medicine journals
and 4,644 articles from the transplantation journals.
A random sample of 5% of all the articles was used in
order to clarify our inclusion and exclusion criteria (see
Table 1 for further details). Following this stage, all of the
1,120 articles published in the internal medicine journals
were read by one of the three researchers, and inclusion
and exclusion criteria were applied. Our final sample from
the internal medicine journals consisted of 349 articles.
For the purposes of comparison, a random sample of
349 out of the 4,644 transplantation journal articles was
created in order to have the same number of articles as in
the internal medicine sample. Two researchers read all
349 articles from the transplantation journals, and applied
the same inclusion and exclusion criteria that were used
for the internal medicine journal articles. When an article
was rejected, it was replaced by the following article in the
list. These articles were proportionally distributed among
the two journals and according to the publication year.
The following characteristics were quantitatively ana-
lyzed: the organ type, the continent of origin of the cor-
responding author, and the article format (research/
clinical trial, brief communication, editorial, etc.). De-
scriptive statistics were used to describe the characteris-
tics of the articles and the chi-squared test was applied.
The articles were analyzed using the content and the-
matic analysis method described by Miles and Huberman
[10]. A random sample of 5% from both the internal medi-
cine and transplantation journals was used to develop our
coding scheme. The main themes in our coding scheme
were: the vocabulary associated with organ transplant-
ation, ethical issues grouped according to Beauchamp and
Childress’ four principles (autonomy, beneficence, non-
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Solid organ transplantation is the
main topic (kidney, liver, heart,
pancreas, lung)
Letters to the editor




• mechanical heart devices;
• stem cell, bone marrow,
composite tissue and pancreatic
islet transplants;
• xenotransplantation.
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ences, and sources of certainty and uncertainty. If the
article described a clinical trial or research study (retro-
spective study, case series, cohort study), only the intro-
duction and conclusion were coded, since the methods,
results and discussion were not pertinent to our ana-
lysis. The computer software QSR NVivo (version 8.0)
was used for the qualitative analysis. Twenty randomly




Approximately two-thirds of the 349 articles retrieved from
the ten internal medicine journals were from the New
England Journal of Medicine and The Lancet. Among the
349 articles retrieved from the two transplantation journals,
77.4% were from Transplantation. There were fewer arti-
cles from American Journal of Transplantation, because itFigure 1 Article distribution.has only been in publication since February 2001 (see
Figure 1 for the distribution of articles).
There was some variation between the internal medicine
and transplantation journals in terms of the distribution of
types of organ transplantation (p < 0.001). Renal trans-
plantation was, however, the most common type in both
journals (42.4% in the transplantation journals and 30.1%
the internal medicine journals). The distribution of article
formats also differed between the two types of journal (p <
0.001). There were more original articles (research and
clinical trials) in the transplantation journals (63.3%) than
in the internal medicine journals (31.8%). Conversely,
there were more brief communications (news, reports,
perspectives, sounding boards, essays) and editorials in the
internal medicine journals (43.3%) than in the transplant-
ation journals (20.6%) (see Table 2 for further details).
Qualitative analysis
In this section, we will first present the vocabulary used to
describe organ transplantation in the two types of journal
articles analyzed. Our aim was to see whether organ trans-
plantation was still portrayed as a routine treatment, as
observed by Fox and Swazey. We will then discuss the
ethical issues raised in the medical journals, grouped
according to Beauchamp and Childress’ four principles
mentioned above [11]. We will also present the patients’
experiences as reported in our sample. Finally, we will look
at how uncertainty was addressed in our journal samples.
Vocabulary used to describe organ transplantation
The vocabulary associated with organ transplantation in
our article sample (similar in both the internal medicine
and transplantation journals) fell into two main categories:






N = 349 (%) N = 349 (%)
Organs P < 0.001
Kidney 105 (30.1) 148 (42.4)
Liver 72 (20.6) 87 (24.9)
Heart 58 (16.6) 25 (7.2)
Lung 26 (7.4) 14 (4.0)
Pancreas 5 (1.4) 3 (0.9)
Multi-organ 37 (10.6) 43 (12.3)




Americas 181 (51.8) 167 (47.9)
Europe 135 (38.7) 154 (44.1)
Other 33 (9.5) 28 (8.0)
Types of articles P < 0.001
Research, clinical
trial
111 (31.8) 221 (63.3)
Brief
communication
110 (31.5) 69 (19.8)
Review 46 (13.2) 23 (6.6)
Editorial 41 (11.7) 3 (0.9)
Case report 21 (6.0) 31 (8.9)




3 (0.9) 0 (0)
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plantation as a routine treatment.
Most of the wording associated with the evolution of
organ transplantation was very positive and even em-
phatic. The most frequently used terms were “success” (18
articles) and “improvement” (21 articles). The successes of
organ transplantation were described as “remarkable,” [12]
“unprecedented,” [13] “great” [14] and “striking” [15]. In
approximately half of these articles, the words “success”
and “improvement” were related to immunosuppressive
drugs. The results of organ transplantation were seen to
be synonymous with success and also with improvement
and progress (8 articles): “Over the last 10 years, impres-
sive progress has occurred in the 1-year patient and allo-
graft survival rates after renal transplantation” [16].
The discovery of new immunosuppressive drugs and
improved prevention of viral complications post-
transplantation were associated with a “revolution” (7 arti-
cles) and were qualified as an “advance” (12 articles). The
word “advance” was also used to describe all the improve-
ments that have occurred in the field of transplantation,
which have translated into positive outcomes for patientsand organ survival: “Due to advances in organ preser-
vation, surgical techniques and immunosuppressive
agents . . . the 1-year patient and graft survival following
organ transplantation have reached a zenith” [17].
One of the articles even qualified organ transplant-
ation as “one of the most exciting medical advances in
the late 20th and early 21st centuries” [18].
Although many advances and improvements have been
made in the field of organ transplantation, which explain its
successes, the practice is also described as a routine treat-
ment (19 articles). It has become “commonplace,” [19]
“standard-of-care,” [20] a “standard practice,” [21] an
“established” therapy [22] and an “accepted treatment” [23].
Ethical issues
A total of 84 articles in the internal medicine journals
(24.1%) and 23 articles in the transplantation journals
(6.6%) addressed ethical issues. In the 84 articles from in-
ternal medicine journals, 44% were brief communications,
including news, reports, perspectives, essays and sounding
boards, whereas in the 23 articles from transplantation
journals, 52.2% described research or clinical trials.
The ethical issues identified in our study can be
grouped under the themes of autonomy, beneficence,
non-maleficence and justice as described by Beauchamp
and Childress (see Table 3 for quotations and further de-
tails). The theme of autonomy was discussed mostly in
terms of informed consent, almost exclusively in the in-
ternal medicine journals. Except for a reference to in-
formed consent in the research setting, there was no
information on autonomy in the transplantation journals.
In the internal medicine journals, the issue of informed
consent was discussed from different angles: the consent
of minors or incapacitated adults; patients who refuse
transplantation; the information to be provided by the
transplant team; and the consent of prisoner donors
[24-27]. In the context of organ selling, the autonomy of
buyers and sellers was discussed [28].
The themes of beneficence and non-maleficence, in
both the internal medicine and transplantation journals,
included an evaluation of risks and benefits. Two articles
from the internal medicine journal sample also addressed
the specific issue of pregnancy after renal transplantation
(risks for the mother, graft and fetus) [32,41] and three
articles discussed transplantation from high infectious risk
donors [29,42,43]. Otherwise, risks and benefits were
discussed in terms of: (i) predictable and individualized
methods of risk assessment before registration on the
waiting list [44,45]; (ii) risks and benefits of the transplant-
ation [46-48]; (iii) choice of immunosuppressive drugs
[49,50]; and (iv) transplants on patients with HIV [51,52].
Justice and fairness were the most commonly raised
issues in our article sample (52 articles in the internal
medicine journals and 19 in the transplantation journals).
Table 3 Ethical issues
AUTONOMY (ALMOST EXCLUSIVELY IN INTERNAL MEDICINE JOURNALS)
Informed consent: research, minors, incapacitated adults, refusal,
information provided, marginal organs
“Organs from donors with specified known infections may be considered for
specific recipients—provided there is appropriate informed consent—based
on the urgency of the need for transplantation and the availability of
effective antimicrobial therapies” [29].
“Consent is an important issue and it is clearly in the doctor’s interest to make
sure that it is based on complete and explicit discussion of known risks” [30].
“Hannah Jones persuaded Herefordshire Primary Care Trust that she was
competent to make her own decisions about medical treatment and was
making an informed choice not to have the operation that could have
prolonged her life” [25].
“A clear and comprehensive informed consent process is necessary,
including a thorough and easily understood informed consent document.
To control for conflicts of interest, informed consent should be obtained
by independent third parties and should include counselling on all
aspects of the risks and benefits of the experimental study” [31].
Organ market: sellers’ and buyers’ autonomy “Paying for a kidney donation is viewed as a potential win-win situation that
can benefit both parties. Individual decision making and patient autonomy
have become the final arbiters of medical and bioethical values” [28].
BENEFICENCE (BOTH TYPES OF JOURNALS)
Risks vs. benefits: assessment methods, pregnancy (only in IM
journals), transplantation with marginal donor, choice of
medication, HIV patients
“Physicians should discuss the risks and benefits of the various
immunosuppressive regimens with respect to pregnancy and the fetus
with their female patients and make decisions collaboratively” [32].
“Adequate graft function requires lifelong immunosuppressive treatment,
and the resultant modification of the immune system is associated with an
increased risk of various cancers, particularly those involving viruses” [33].
“In cases in which the need for transplantation is relatively less urgent, it is
reasonable to avoid the use of organs from donors with unexplained
fever, rash, encephalitis, or untreated infectious syndromes” [29].
“This knowledge raised the intriguing possibility that the
immunosuppression used to prevent rejection might be beneficial for
patients with HIV disease that had been successfully controlled by
antiretroviral agents” [34].
JUSTICE (BOTH TYPES OF JOURNALS)
Organ allocation “It is a relevant difference. You want to make sure you get the appropriate
use of the appropriate resources. That is ethically not questionable at all.
We do this rationalization of resources in health care every day” [35].
“Because transplantable organs are scarce, determining the most ethical
allocation system requires simultaneous considerations of efficacy,
urgency, and equity” [36].
“As stewards of a precious resource, the transplant community has a goal
of achieving an equitable, transparent, and efficient system of organ
allocation” [37].
Disparities in access to organ transplantation
(gender, ethnicity, geography)
“We believe that the United States should end policies that permit
geographic inequities and move quickly to determine the best use of
data on the efficacy of outcomes to create a more equitable national
system of distribution” [38].
“The federal government should expect dialysis programs to meet
reasonable standards for equitable access to transplantation for all
patients, regardless of race, sex, or social status” [39].
Personal responsibilities and organ transplantation “Even though the issue of personal responsibility for organ failure is
usually raised in the literature with regard to whether patients who abuse
alcohol should be given a lower priority for an organ, a similar argument
could be made that a woman who wittingly chooses to get pregnant
when her graft is unstable (and who therefore has an increased risk of
graft loss) should be given a lower priority for retransplantation” [32].
“A British liver transplant specialist last week accused colleagues of taking a
decision on moral rather than medical grounds when they refused a transplant
to a teenage girl with liver failure after she took half an ecstasy tablet” [40].
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plantation and second transplantations [32,53]. In a simi-
lar vein, there was discussion about whether risk factors
such as alcoholism should be taken into account in access
to transplantation [54,55]. Also widely discussed was how
gender, ethnic, geographic and socio-economic differences
affect access to transplantation [37,56]. Young & Gaston
noted that “. . . the median waiting time for a cadaveric
kidney is almost twice as long (1185 vs. 605 days) for a
black candidate as for a white one” [57].
Another issue raised was organ allocation and the organ
shortage, which was described as a “huge and growing
gap” [58] and “stark disparity” [59] between supply and de-
mand which some felt would probably never abate [60].
There was a lot of uncertainty around what constitutes a
sound organ allocation policy. Principles evoked included
equity, equal chances, medical urgency, transparency, effi-
cacy and decisions based on the disease causing organ fail-
ure. One article proposed hope (patients’ anticipation of
being transplanted) as a principle of organ allocation [61].
Some articles also noted the size of the pool of potential
recipients and questioned whether there should be an age
limit for access to transplantation, and whether marginal
donors should be allocated to older patients. The trans-
plant community is held to high ethical standards—one
article described its members as “stewards of a precious
resource” [37].
Patients’ experiences
A total of 18 (5.2%) articles from the internal medicine
journals and 6 (1.7%) from the transplantation journals
looked at patients’ experiences and feelings. Both positive
and negative feelings were reported. Before transplant-
ation, patients’ anticipation of the phone call announcing
the availability of an organ was reported as a positive feel-
ing [62]. Trust, well-being, increased energy, enthusiasm
and gratitude for being alive were the positive feelings
reported after the transplantation [63,64]. On the negative
side, feelings of anxiety and depression were reported be-
fore and after the transplantation. Also noted was despair
and anguish while waiting for the transplantation [65,66].
After the transplantation, there can be feelings of shame
associated with non-compliance, as well as fear of rejec-
tion, frustrations and distress [67,68]. In addition to these
findings, some articles reported mixed feelings such as
“strength in weakness, hope in despair, wholeness in
brokenness and life in potential death” [62] (see Table 4
for further details).
Opposition between certainty and uncertainty
Feelings of uncertainty were equally present in the in-
ternal medicine journals (28 articles or 8%) and trans-
plantation journals (37 articles or 10.6%) [61,71,72]. All
aspects of organ transplantation were reported to be asource of uncertainty for patients and physicians: the
quality of organ; the impact of organ transplantation on
the patient’s quality of life; predictors of the patient’s and
graft’s survival; the choice of treatment; possible com-
plications and physiopathologic mechanisms. The only
sources of certainty reported were graft loss in cases of
non-compliance and death without transplantation [73,74]
(see Table 5 for further details).
Discussion
This is the first study to look at the non-biomedical as-
pects of organ transplantation reported in internal
medicine and transplantation journals. These aspects
include the language used to describe the procedure,
bioethical issues, patients’ experiences and uncertainty.
One strength of this study is the fact that we analyzed
all the articles in the top ten internal medicine journals
in which organ transplantation was the main topic,
thus obtaining an accurate sense of how the practice is
covered in this type of publication.
The terms used to describe the evolution of trans-
plantation are generally very positive. Of course, organ
transplantation is one of the major medical advances of
our times. Patients whose condition was formerly a
death sentence now have the promise of a new lease on
life. In the words of Barbara Koenig, organ transplantation
is part of the spectrum of end-of-life technologies since it
is “deployed to stave off death” [75]. This positive em-
phasis is associated with the idea of progress. As Plough
notes, progress in the West is associated with techno-
logical control and mastery of the body [76]. Organ
transplantation in the case of organ failure is a prime
example of this. Interestingly, at the same time as organ
transplantation is described in terms of progress and
scientific advances, it is also increasingly portrayed as a
routine and commonplace treatment. Barbara Koenig
defines a routine treatment as one that is not experi-
mental or innovative; that is widely accepted in clinical
practice; that involves typical hierarchical relationships
between physicians, nurses, patients; and that has its
own rituals. When a treatment becomes routine, physi-
cians have a moral imperative to provide it and patients
feel entitled to it [77]. The routinization of organ trans-
plantation is no doubt one of the factors behind the
ever-widening gap between the number of patients on
the waiting list and the number of organs available. It is
possibly also a factor behind the growing number of pa-
tients and families who launch public media appeals to
plead their case for transplantation [78]. However, is it
fair to describe organ transplantation as a routine treat-
ment, considering all the issues involved in the transfer
of an organ from one person to another [79,80]? How
do we reconcile the highly technological and symbolic
nature of organ transplantation with the fact that it has
Table 4 Patients’ experiences
POSITIVE
FEELINGS
“We jumped to answer each phone call, and our pager became the beeper of hope” [62].
“Physically I was amazed at how well I held out. I felt really strong. My heart seemed to respond so well” [69].
“With an organ transplantation, there is often a rebirth—a renewed awareness of the quality of life . . . It is not uncommon to see
people pursue some dream which was put on a backburner because they were too busy or it was considered out of reach” [69].
NEGATIVE
FEELINGS
“At one point during the year and a half, I experienced a deep depression, thinking ‘Why me’” [70]?
“Not surprisingly, this can lead to anguish and acts of desperation for those who wait” [65].
“Among the psychological variables it is above all anxiety, anger/hostility, and denial that may cause compliance problems. High
level of anxiety was reported to be consistently the most important predictor” [67].
“Most patients will not divulge nonadherence, not only because of shame and embarrassment, but also because admitting to
nonadherence may make them less desirable candidates for retransplantation” [68].
MIXED FEELINGS “The past year has been painful and unforgettable. Our faith in God has been our greatest resource: we discovered strength in
weakness, hope in despair, wholeness in brokenness and life in potential death” [62].
Durand et al. BMC Medical Ethics 2013, 14:39 Page 7 of 10
http://www.biomedcentral.com/1472-6939/14/39become the standard of care for patients suffering from
organ failure?
As mentioned above, ethical issues (24.1% of internal
medicine articles vs. 6.6% of transplantation articles) and
patients’ feelings about transplantation (5.2% of internal
medicine articles vs. 1.7% of transplantation articles)
were reported more frequently in the internal medicine
journals than in the transplantation journals. This can
be explained by the different distribution of article formats
in both types of journals. There were more editorials and
brief communications in the internal medicine journals—
formats that are more amenable to discussions of bio-
ethical or social issues. One might conclude that it is not
the role of transplantation journals to discuss social and
ethical issues, since their aim is to publish recent scientific
advances in the field of organ transplantation for physi-
cians and scientists specialized in this field, whereas in-
ternal medicine journals target a wider medical audience.
However, it is stated on the American Journal of Trans-
plantation website that the journal’s scope includes ethical
and social issues related to organ transplantation [81]. The
journal Transplantation also has a special section (the
Forum) devoted to ethical and controversial issues [82].
How to explain the contrast between these claims and
scant coverage of ethical issues and patients’ experiences
in our transplant journal sample? Should there not be
more coverage of patients’ lives post-transplantation inTable 5 Certainty and uncertainty
SOURCES OF
UNCERTAINTY
“The immediate implications of the data on ABO-i
“Information regarding their prognosis (i.e., predict
are starting to emerge, although considerable unc
“Some patients may prefer early resolution of unce
process changes their time horizon with respect to
SOURCES OF
CERTAINTY
“There are a number of ways to approach diagnos
direct patient admission of nonadherence to the p
“Therefore, whereas 20 years ago death was a nea
transplantation was regarded as a bonus, in the pr
alternative treatments” [63].transplantation journals, in order to remind transplant
professionals that “life after a transplant is not like life be-
fore the disease [leading to transplant] entered the stage”
[83]? Is there a discrepancy between the asserted scope of
the journal and the editors’ choices of articles for pub-
lication? It is important to bear in mind that these two
transplantation journals are those most read by profes-
sionals involved in the field. Given that the transplantation
community is confronted on a daily basis with the prac-
tical problems of organ transplantation such as rejection
and complications, has it become blinded to the non-
biomedical aspects of the procedure? Does this reflect
what Fox and Swazey described as the ethos of the trans-
plant physician, which involves a heroic, pioneering, opti-
mistic attitude and a refusal to accept limits [4]? Does it
also reflect a division between transplant surgeons, who
are mostly concerned with organ recipients, and internal
medicine physicians, who focus on organ donors (living or
deceased)? If we consider that ethical and social issues in
transplantation do not have any legitimacy in scientific
journals and should be addressed only in bioethics or so-
cial science journals, transplant professionals will have less
to contribute to the ethical debate. Further studies are
needed to explore these questions.
The ethical issues reported in the transplantation and in-
ternal medicine articles in this study can be grouped under
Beauchamp and Childress’ four principles as described inncompatible heart transplantation in infants are uncertain” [71].
ed survival without transplant and recommendations for timing of listing
ertainty remains” [72].
rtainty to delay, especially if knowing the outcome of the allocation
financial decisions” [61].
is of the noncompliance syndrome, but the only certainty comes from
rescribed immunosuppression” [74].
r certainty without a transplant, and any length of survival after heart
esent era some patients potentially have a similar prognosis with
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ical Ethics [11]. This is not surprising, since their biomed-
ical ethics approach is that most widely taught and applied
in the medical field. However, we might question whether
these four principles really capture all the ethical dimen-
sions of organ transplantation.
Organ transplantation raises a number of ethical is-
sues (living donation, gift exchange, incentives, etc.)
which did not appear in our samples, most likely be-
cause we excluded articles on organ donation. This is
one major limitation of our study. However, we wanted
to focus on organ transplantation as we did in our ana-
lysis of Quebec newspapers. One of the most important
ethical issues raised in the medical and transplantation
journals was fairness in organ allocation, as it was in
our sample of newspaper articles [7]. This could reflect
the challenge of striking a balance between equity and
medical utility in organ allocation policies. It is interest-
ing to note that this issue has not been resolved in the
more than 50 years that transplantation programs have
been in existence [11].
Few of the articles in our sample looked at patients’ feel-
ings about transplantation. In our previous study on por-
trayals of transplantation in Quebec newspapers, a
significant number of articles described patients’ and their
relatives’ perspectives on organ transplantation. The news-
paper articles conveyed the despair of patients waiting for
an organ and their return to a normal life following the
transplantation. They also mentioned the transplanted
patients’ exploits [7]. One might question whether both
the newspapers and scientific articles examined truly con-
veyed transplant patients’ experiences. Previous studies on
Irish renal transplanted patients showed that while they
publicly described the benefits of the procedure and their
enhanced well-being in order to show their gratitude for
the gift of life, in private, they described their sickness,
loneliness and mixed feelings about organ transplantation
[3,80,84]. Is there a place for patients to give a frank ac-
count of their transplant experience and what success
means to them?
A small number of articles in this study addressed the
issue of uncertainty related to organ transplantation. In
these articles, the entire process was described as uncer-
tain, in contrast to what we found in our previous study
on Quebec newspapers, where the uncertainty was re-
lated to whether or not the patient would receive an
organ, but not to the outcomes of the procedure, which
were invariably seen as positive [7].
Is there an overidealization of organ transplantation as
described by Fox and Swazey? These two scholars referred
to the tendency, in organ replacement, to overidealize the
quality and duration of the life of transplanted patients,
resulting in “seemingly limitless attempts to procure and
implant organs” [4]. The positive vocabulary associatedwith the evolution of transplantation; the routine charac-
ter of organ transplantation, which makes patients feel en-
titled to this treatment; the relatively few articles on the
ethical issues associated with organ transplantation and on
the real experiences of transplanted patients; and the por-
trayal of the organ shortage as an obstacle to be overcome
could reflect an overidealization of the procedure and lead
patients to seek transplantation at all costs (e.g., travelling
to purchase an organ or publicly soliciting an organ via
various media).
Conclusions
Our study is the first to look at the non-biomedical aspects
of organ transplantation (language, ethical issues, patients’
experiences) as portrayed in medical and transplantation
journals. Our analysis shows that medical journal articles
tend to describe the evolution of organ transplantation in
positive terms and present it as a routine treatment. We
can question whether this routinization of organ transplant-
ation is related to the relatively small number of articles ad-
dressing ethical issues.
That said, organ transplantation was also described as
uncertain in our sample of medical and transplantation
journal articles. All aspects of organ transplantation are a
source of uncertainty. This finding differs from that of our
previous study on the portrayal of organ transplantation in
Quebec newspapers, where the only uncertainty was related
to the wait for an organ [7]. How to explain this difference
in portrayals of uncertainty? Can the difference be attrib-
uted to certain journalistic practices aimed at creating “feel
good” stories, [85] or does the greater number of success
stories in newspapers reflect the medical and transplant
community’s desire to promote organ donation [86]?
Although the organ shortage was one of the main
ethical issues addressed in our sample of transplant-
ation and internal medicine articles, it was rarely
questioned. The medical community has a role to play
in this shortage, since improvements in the field have
led physicians to transplant patients who would previ-
ously not have been considered suitable candidates.
The emphasis on the organ shortage in internal medi-
cine and transplantation journals could imply it is a
problem that can be solved and that all patients can be
transplanted, including older and sicker patients. Is
this a consequence of what Fox and Swazey, after
working for decades in the field of organ transplant-
ation, described as the “triumphalist” attitude of pro-
fessionals in the face of death the enemy [4]? Does this
emphasis on the organ shortage affect donor policies such
as incentives, the acceptance of living anonymous donors,
etc.? Further studies are needed to explore perspectives
within the medical and transplant communities, as well as
the general public’s views on the organ shortage and its re-
lation to death, end-of-life care and health policies.
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results of this study? Would they have considered
returning to the field of organ transplantation? Their de-
scription of the routinization of the procedure and the
ethos of transplant professionals characterized by an op-
timistic and heroic perspective are still present in the
medical literature. The theme of uncertainty in organ
transplantation is also present, but not to the same de-
gree. The few articles that reported on patients’ experi-
ences of organ transplantation presented some of the
negative sides of the procedure. Finally, the articles ana-
lyzed in this study did not question the financial invest-
ment in organ transplantation compared to other forms
of healthcare. Fox and Swazey’s criticisms are clearly still
relevant, two decades later. Transplant professionals
should be careful to maintain a critical stance with re-
gard to the transplant process and should keep sight of
the fact that it has moral, social and personal costs.
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